Evercel Inc. | Income Statement

Fiscal year is April-March. All values USD Thousands.
2015
2016
Sales/Revenue
84,119.00
66,491.00
Cost of Goods Sold (COGS) incl. D&A
46,133.00
38,585.00
Gross Income
37,986.00
27,906.00
SG&A Expense
34,520.00
32,500.00
EBIT
-
4,594.00
Unusual Expense
139.00
7,423.00
Non Operating Income/Expense
974.00
103.00
Interest Expense
73.00
73.00
Pretax Income
4,228.00
12,193.00
Income Tax
1,927.00
2,440.00
Consolidated Net Income
2,301.00
14,633.00
Net Income
2,326.00
15,267.00
Net Income After Extraordinaries
2,913.00
42,017.00
Net Income Available to Common
7,497.00
13,273.00
EPS (Basic)
0.23
0.35
Basic Shares Outstanding
32,530.60
32,530.60
EPS (Diluted)
0.23
0.35
Diluted Shares Outstanding
32,562.70
32,530.60
EBITDA
9,713.00
1,023.00
Minority Interest Expense
25.00
634.00
Preferred Dividends
68.00
73.00

About Evercel

View Profile
Address
5 Pond Park Road
Hingham Massachusetts 02043
United States
Employees -
Website http://www.evercel.com
Updated 07/08/2019
Evercel, Inc. is a holding company, which engages in overseeing and management of its subsidiary companies and portfolio investments. It owns and manages the New England Crab Company Incorporated, Sontek Medical Incorporated, and Evercel Pioneer Holding Corporation. The company was founded on February 09, 1999 and is headquartered in Hingham, MA.